Related references
Note: Only part of the references are listed.REPEATED COURSES OF GRANULOCYTE COLONY-STIMULATING FACTOR IN AMYOTROPHIC LATERAL SCLEROSIS: CLINICAL AND BIOLOGICAL RESULTS FROM A PROSPECTIVE MULTICENTER STUDY
Adriano Chio et al.
MUSCLE & NERVE (2011)
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis Examining a more efficient trial design
R. G. Miller et al.
NEUROLOGY (2011)
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Mariely DeJesus-Hernandez et al.
NEURON (2011)
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Alan E. Renton et al.
NEURON (2011)
A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis
Robert M. Pascuzzi et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study
Beatrice Nefussy et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis
Mamede De Carvalho et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
Clinical Trials for Neuroprotection in ALS
G. Siciliano et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
Current Nervous System Related Drug Targets for the Treatment of Amyotrophic Lateral Sclerosis
Aaron C. Pawlyk et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Cellular transplants in amyotrophic lateral sclerosis patients: an observational study
Josep Gamez et al.
CYTOTHERAPY (2010)
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis
Stefania Corti et al.
HUMAN MOLECULAR GENETICS (2010)
Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type
Samuel M. Cadena et al.
JOURNAL OF APPLIED PHYSIOLOGY (2010)
Induction of Protective Immunity by Vaccination With Wild-Type Apo Superoxide Dismutase 1 in Mutant SOD1 Transgenic Mice
Shigeko Takeuchi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
Swati P. Aggarwal et al.
LANCET NEUROLOGY (2010)
Inflammation in ALS and SMA: Sorting out the good from the evil
Dimitra Papadimitriou et al.
NEUROBIOLOGY OF DISEASE (2010)
Lithium carbonate in amyotrophic lateral sclerosis Lack of efficacy in a dose-finding trial
A. Chio et al.
NEUROLOGY (2010)
Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALS
Adrian Israelson et al.
NEURON (2010)
IN VITRO AND IN VIVO CHARACTERIZATION OF TAPENTADOL METABOLITES
R. Terlinden et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2010)
Screening for inhibitors of the SOD1 gene promoter: Pyrimethamine does not reduce SOD1 levels in cell and animal models
Paul D. Wright et al.
NEUROSCIENCE LETTERS (2010)
Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis
D. Keizman et al.
ACTA NEUROLOGICA SCANDINAVICA (2009)
Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial
Elijah W. Stommel et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis
Yuanjin Zhang et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double-blind, randomized, multicentre, placebo-controlled trial
Vincent Meininger et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Phase II Trial of CoQ10 for ALS Finds Insufficient Evidence to Justify Phase III
Petra Kaufmann et al.
ANNALS OF NEUROLOGY (2009)
Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up
H. Deda et al.
CYTOTHERAPY (2009)
Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients
Hector R. Martinez et al.
CYTOTHERAPY (2009)
Human Neural Stem Cell Grafts in the Spinal Cord of SOD1 Transgenic Rats: Differentiation and Structural Integration into the Segmental Motor Circuitry
Leyan Xu et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2009)
Electrical impedance myography as a biomarker for ALS
Seward Rutkove
LANCET NEUROLOGY (2009)
AUTOPHAGY, LITHIUM, AND AMYOTROPHIC LATERAL SCLEROSIS
Livia Pasquali et al.
MUSCLE & NERVE (2009)
APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Anatoly Nikolaev et al.
NATURE (2009)
Amyotrophic lateral sclerosis
Lokesh C. Wijesekera et al.
ORPHANET JOURNAL OF RARE DISEASES (2009)
Methazolamide and Melatonin Inhibit Mitochondrial Cytochrome C Release and Are Neuroprotective in Experimental Models of Ischemic Injury
Xin Wang et al.
STROKE (2009)
Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis
Claudia Pitzer et al.
BRAIN (2008)
T cells in amyotrophic lateral sclerosis
T. Holmoy
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Thalidomide causes sinus bradycardia in ALS
Thomas Meyer et al.
JOURNAL OF NEUROLOGY (2008)
Small molecule enhancers of autophagy for neurodegenerative diseases
Sovan Sarkar et al.
MOLECULAR BIOSYSTEMS (2008)
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
Andrea Williams et al.
NATURE CHEMICAL BIOLOGY (2008)
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
E. J. Sorenson et al.
NEUROLOGY (2008)
Lithium delays progression of amyotrophic lateral sclerosis
Francesco Fornai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CD4+T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS
David R. Beers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis
Sharah Hosback et al.
GROWTH HORMONE & IGF RESEARCH (2007)
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H. Gordon et al.
LANCET NEUROLOGY (2007)
Small molecule regulators of autophagy identified by an image-based high-throughput screen
Lihong Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Phase II/III randomized trial of TCH346 in patients with ALS
R. Miller et al.
NEUROLOGY (2007)
Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis
Thierry Bordet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALS
Hans-Joerg Habisch et al.
EXPERIMENTAL NEUROLOGY (2007)
Genetic Variant in the HSPB1 Promoter Region Impairs the HSP27 Stress Response
Ines Dierick et al.
HUMAN MUTATION (2007)
Functional motoneurons develop from human neural stem cell transplants in adult rats
Junling Gao et al.
NEUROREPORT (2007)
Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis
Makoto Urushitani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment
Jochen H. Weishaupt et al.
JOURNAL OF PINEAL RESEARCH (2006)
Induction of multiple heat shock proteins and neuroprotection in a primary culture model of familial amyotrophic lateral sclerosis
Zarah Batulan et al.
NEUROBIOLOGY OF DISEASE (2006)
The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model
Natasa Jokic et al.
EMBO REPORTS (2006)
Degradation of amyotrophic lateral sclerosis-linked mutant Cu,Zn-superoxide dismutase proteins by macroautophagy and the proteasome
Tomohiro Kabuta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Extracellular regulators of axonal growth in the adult central nervous system
Betty P. Liu et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2006)
Antisense oligonucleotide therapy for neurodegenerative disease
Richard A. Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Neuroprotective agents for clinical trials in ALS - A systematic assessment
B. J. Traynor et al.
NEUROLOGY (2006)
Trial of celecoxib in amyotrophic lateral sclerosis
Merit E. Cudkowicz et al.
ANNALS OF NEUROLOGY (2006)
Randomized controlled phase II trial of glatiramer acetate in ALS
PH Gordon et al.
NEUROLOGY (2006)
Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis
M Kiaei et al.
JOURNAL OF NEUROSCIENCE (2006)
Pentoxifylline in ALS - A double-blind, randomized, multicenter, placebo-controlled trial
V Meininger et al.
NEUROLOGY (2006)
Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+)2-amino-4,5,6,7-tetrahydro-6-L-propylamino-benzathiazole dihydrochloride]
R Danzeisen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Audit of outcomes in motor neuron disease (MND) patients treated with riluzole
J. Douglas Mitchell et al.
AMYOTROPHIC LATERAL SCLEROSIS (2006)
Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model
RG Wang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
An epidemiological study of motor neuron disease in Hong Kong
GCY Fong et al.
AMYOTROPHIC LATERAL SCLEROSIS (2005)
Manganese porphyrin given at symptom onset markedly extends survival of ALS mice
JP Crow et al.
ANNALS OF NEUROLOGY (2005)
Autonomic dysfunction in ALS: A preliminary study on the effects of intrathecal BDNF
M Beck et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2005)
Autophagy in metazoans: Cell survival in the land of plenty
JJ Lum et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS
C Raoul et al.
NATURE MEDICINE (2005)
Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity
N Jokic et al.
ANNALS OF NEUROLOGY (2005)
An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients
M Sohmiya et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
JD Rothstein et al.
NATURE (2005)
Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS
E Storkebaum et al.
NATURE NEUROSCIENCE (2005)
Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice
D Kieran et al.
NATURE MEDICINE (2004)
IGF-I prevents glutamate-induced motor neuron programmed cell death
AM Vincent et al.
NEUROBIOLOGY OF DISEASE (2004)
CGP 3466B has no effect on disease course of (G93A) mSOD1 transgenic mice
GJ Groeneveld et al.
AMYOTROPHIC LATERAL SCLEROSIS (2004)
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials
V Meininger et al.
AMYOTROPHIC LATERAL SCLEROSIS (2004)
Xaliproden in amyotrophic lateral sclerosis: early clinical trials
L Lacomblez et al.
AMYOTROPHIC LATERAL SCLEROSIS (2004)
The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons
RE Castro et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS
CY Zheng et al.
ANNALS OF NEUROLOGY (2004)
Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis
PH Gordon et al.
NEUROLOGY (2004)
Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice
H Guo et al.
HUMAN MOLECULAR GENETICS (2003)
Expression and localization of cyclooxygenase-1 and-2 in human sporadic amyotrophic lateral sclerosis
C Maihöfner et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis
ME Cudkowicz et al.
NEUROLOGY (2003)
Bimoclomol, a heat shock protein co-inducer, acts by the prolonged activation of heat shock factor-1
J Hargitai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters
H Ryberg et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
An outcome study of riluzole in amyotrophic lateral sclerosis - A population-based study in Ireland, 1996-2000
BJ Traynor et al.
JOURNAL OF NEUROLOGY (2003)
Inducible cAMP early repressor (ICER) in the nervous system - a transcriptional regulator of neuronal plasticity and programmed cell death
B Mioduszewska et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS
DB Drachman et al.
ANNALS OF NEUROLOGY (2002)
Minocycline slows disease progression in a mouse model of arnyotrophic lateral sclerosis
J Kriz et al.
NEUROBIOLOGY OF DISEASE (2002)
Minocycline delays disease onset and mortality in a transgenic model of ALS
L Van Den Bosch et al.
NEUROREPORT (2002)
A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis
G Bensimon et al.
JOURNAL OF NEUROLOGY (2002)
Coenzyme Q10 as a possible treatment for neurodegenerative diseases
MF Beal
FREE RADICAL RESEARCH (2002)
Cost effectiveness of treatments for amyotrophic lateral sclerosis - A review of the literature
G Ginsberg et al.
PHARMACOECONOMICS (2002)
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration
B Oosthuyse et al.
NATURE GENETICS (2001)
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis
RG Miller et al.
NEUROLOGY (2001)
A double-blind, placebo-controlled randomized clinical trial of α-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis
C Desnuelle et al.
AMYOTROPHIC LATERAL SCLEROSIS (2001)
Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice
C Ladecola et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Ca2+-permeable AMPA receptors and selective vulnerability of motor neurons
L Van Den Bosch et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2000)
N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis
OA Andreassen et al.
NEUROREPORT (2000)
Share Paper
